(S (NP-SBJ (JJ Elevated) (JJ cyclic) (NN AMP)) (VP (VBZ inhibits) (NP (NP (JJ NF-kappaB-mediated) (NN transcription)) (PP (IN in) (NP (JJ human) (NP-COOD (NP (JJ monocytic) (NNS cells)) (CC and) (NP (JJ endothelial) (NNS cells))))))) (. .))
(S (NP-SBJ (NP (DT The) (NN (Rel NF-kappaB)) (NN family)) (PP (IN of) (NP (NN transcription) (NNS factors)))) (VP (VBZ regulates) (NP (NP (DT the) (JJ inducible) (NN expression)) (PP (IN of) (NP (JJ many) (NNS genes))) (PP (IN in) (NP (VBN activated) (JJ human) (NP-COOD (NP (NNS monocytes)) (CC and) (NP (JJ endothelial) (NNS cells))))))) (. .))
(S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP-SBJ (PRP we)) (VP (VBD examined) (NP (NP (DT the) (JJ molecular) (NN mechanism)) (SBAR (WHPP-22 (IN by) (WHNP (WDT which))) (S (NP-SBJ (NP (NNS agents)) (SBAR (WHNP-23 (WDT that)) (S (NP-SBJ (-NONE- *T*-23)) (VP (VBP elevate) (NP (JJ intracellular) (NN cAMP)))))) (VP (VBP inhibit) (NP (NP (DT the) (NN expression)) (PP (IN of) (NP (DT the) (NP-COOD (NP (NP (NN tumor) (NN necrosis) (NN factor) (NN alpha)) (PRN (-LRB- -LRB-) (NP (NN TNFalpha)) (-RRB- -RRB-))) (, ,) (NP (NN tissue) (NN factor)) (, ,) (NP (JJ endothelial) (NN leukocyte) (NN adhesion) (NN molecule-1)) (, ,) (CC and) (NP (JJ vascular) (NN cell) (NN adhesion) (NN molecule-1))) (NNS genes)))) (PP (-NONE- *T*-22))))))) (. .))
(S (NP-SBJ (NP-COOD (CC Both) (NP (NN forskolin)) (CC and) (NP (NN dibutyryl) (NN cAMP))) (, ,) (SBAR (WHNP-24 (WDT which)) (S (NP-SBJ (-NONE- *T*-24)) (VP (VBP elevate) (NP (JJ intracellular) (NN cAMP)) (PP (IN by) (NP (JJ independent) (NNS mechanisms)))))) (, ,)) (VP (VBD inhibited) (NP (NP-COOD (NP (NN TNFalpha)) (CC and) (NP (NN tissue) (NN factor))) (NN expression)) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN transcription)))))) (. .))
(S (NP-SBJ-25 (NP (NN Induction)) (PP (IN of) (NP (JJ NF-kappaB-dependent) (NN gene) (NN expression))) (PP (IN in) (NP (ADJP (RB transiently) (VBN transfected)) (NP-COOD (NP (JJ human) (JJ monocytic) (NN THP-1) (NNS cells)) (CC and) (NP (JJ human) (JJ umbilical) (NN vein) (JJ endothelial) (NNS cells)))))) (VP (VBD was) (VP (VBN inhibited) (NP (-NONE- *-25)) (PP-COOD (PP (IN by) (NP-LGS (JJ elevated) (NN cAMP))) (CC and) (PP (IN by) (NP-LGS (NP (NN overexpression)) (PP (IN of) (NP (NP (DT the) (JJ catalytic) (NN subunit)) (PP (IN of) (NP (NP (NN protein) (NN kinase) (NN A)) (PRN (-LRB- -LRB-) (NP (NN PKA)) (-RRB- -RRB-))))))))))) (. .))
(S (NP-SBJ (JJ Elevated) (NN cAMP)) (VP (VBD did) (RB not) (VP-COOD (VP (VB prevent) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NP-COOD (NP (NN (p65 p50))) (CC and) (NP (NN (p65 c-Rel)))) (NNS heterodimers))))) (, ,) (VP (VB decrease) (NP (NP (JJ nuclear) (NN translocation)) (PP (IN of) (NP (NN p65))))) (, ,) (CC or) (VP (ADVP (RB significantly)) (VB modify) (NP (NP (JJ TNFalpha-induced) (NN phosphorylation)) (PP (IN of) (NP (NN p65))))))) (. .))
(S (NP-SBJ (JJ Functional) (NNS studies)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ-26 (NP (JJ transcriptional) (NN activation)) (PP (IN of) (NP (NP (DT a) (NN plasmid)) (VP (VBG containing) (NP (JJ multimerized) (NN kappaB) (NNS sites))))) (PP (IN by) (NP (NN p65)))) (VP (VBD was) (VP (VBN inhibited) (NP (-NONE- *-26)) (PP-COOD (PP (IN by) (NP-LGS (NP (NNS agents)) (SBAR (WHNP-27 (IN that)) (S (NP-SBJ (-NONE- *T*-27)) (VP (VBP elevate) (NP (NN cAMP))))))) (CC and) (PP (IN by) (NP-LGS (NP (NN overexpression)) (PP (IN of) (NP (NP (DT the) (JJ catalytic) (NN subunit)) (PP (IN of) (NP (NN PKA))))))))))))) (. .))
(S (NP-SBJ (DT This) (NN study)) (VP (VBZ indicates) (SBAR (IN that) (S (NP-SBJ-28 (NP (NN activation)) (PP (IN of) (NP (NN PKA)))) (VP (VBZ reduces) (NP (NP (DT the) (NN induction)) (PP (IN of) (NP (NP (DT a) (JJ distinct) (NN set)) (PP (IN of) (NP (NNS genes))))) (PP (IN in) (NP-COOD (NP (NNS monocytes)) (CC and) (NP (JJ endothelial) (NNS cells))))) (PP (IN by) (S (NP-SBJ (-NONE- *-28)) (VP (VBG inhibiting) (NP (JJ NF-kappaB-mediated) (NN transcription))))))))) (. .))
